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NanoDrop spectrophotometry and NanoDrop ﬂuorospectrometry are used almost exclusively to deter-
mine the concentrations of nucleic acids and proteins. We propose that NanoDrop ﬂuorospectrometry
can also be applied for measuring enzyme activities using ﬂuorogenic substrates such as the proteolytic
activities of the 26S proteasome. Because the NanoDrop ND-3300 device requires only 2 ll of sample, the
amount of sample extract, substrate, and cofactors used for an enzyme assay can be signiﬁcantly reduced.
In this report, we present exemplary microassays for proteasomal activities (chymotrypsin-, trypsin-, and
PGPH [peptidyl-glutamyl peptide hydrolase]-like sites) in extracts of isolated hemocytes from a marine
crab, Cancer pagurus (Crustaceae).
 2011 Elsevier Inc. All rights reserved.
The use of highly sensitive ﬂuorogenic substrates is becoming
increasingly relevant not only in analytical and clinical enzymol-
ogy but also in various other ﬁelds of life sciences, including bio-
chemical, physiological, and biomedical research. Particularly
important applications include the design of artiﬁcial substrates
for use as a tool in cytology and pathology [1,2]. In this respect,
the discovery of the intracellular ubiquitin-mediated proteolytic
pathway and the controlled degradation of waste proteins by the
multi-enzyme complex called 26S proteasome [3,4] has opened
another important ﬁeld for ﬂuorometric enzyme assays [5–7].
Fluorogenic substrates as well as enzyme effectors may be quite
expensive or available in limited amounts; the latter is particularly
relevant if their isolation from natural sources is laborious or they
are synthesized in small amounts for speciﬁc applications. There-
fore, it would be ideal if the amount of substrate used per assay
could be decreased through a reduction in assay volume. This
may lead to a better scientiﬁc exploration of rare drugs. Similarly,
reducing the assay volume may also allow enzymatic analysis
within small medical biopsy samples, cell culture suspensions,
and very small organisms and the parts thereof [8,9].
In our laboratory, we have developed NanoDrop ﬂuorometry for
routine measurements of enzyme activities within small samples.
For example, activities of digestive enzymes have been measured
in small marine invertebrates, and proteolytic enzymes have been
measured in the muscle tissues from individual lobster larvae. In
this report, we describe in detail a method for measuring 26S pro-
teasomal activities in small amounts of hemocyte extracts from
crustaceans. We also demonstrate the sensitivity of this method
and describe its potential applications within various ﬁelds of the
life sciences.
Because the NanoDrop device (ND-3300, version 2.7.0, PEQLAB
Biotechnologie) requires only 1–2 ll of reaction mixture for ﬂuo-
rescent measurement [10], the total volume of the assay was re-
duced signiﬁcantly.
The reproducibility and linearity of the ﬂuorescence signals
were determined with the ﬂuorophore 7-amino-4-methyl couma-
rin (AMC,1 Fluka, product no. 08440). This ﬂuorophore has excitation
and emission wavelengths of 365 and 437 nm, respectively. A stan-
dard curve was prepared using solutions of AMC ranging in concen-
tration from 0 to 20 lM. These solutions were made from stock
ﬂuorophore dissolved in dimethyl sulfoxide (DMSO), which was then
diluted in 26S proteasome assay buffer (50 mM Tris–HCl, 40 mM KCl,
5 mMMgCl2, and 2 mM ATP, pH 8.0). The ﬂuorescence of these stan-
dards was measured concurrently using the NanoDrop device and a
conventional spectroﬂuorometer (Kontron SFM 25). The NanoDrop
device requires 2 ll of solution, whereas the conventional spectro-
ﬂuorometer requires 1 ml of solution in semi-microcuvettes.
Proteasomal activities were assayed in hemocytes isolated from
the hemolymph of the marine crab Cancer pagurus. Using a 1-ml
sterile syringe with a 22-gauge needle, 50–100 ll of hemolymph
was collected by puncturing the intersegmental membrane at the
base of a walking leg. To prevent coagulation, the hemolymph
was mixed in the syringe with at least half a volume of anticoagu-
lant solution (300 mM NaCl, 10 mM KCl, 10 mM Hepes, and 10 mM
ethylenediaminetetraacetic acid [EDTA], pH 7.3). After collection,
the hemolymph samples were transferred into 1.5-ml reaction
tubes and centrifuged for 10 min at 600g and 10 C. The superna-
tants were then discarded, and the pellets containing the hemo-
cytes were resuspended in 100 ll of 26S proteasome assay
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buffer. The suspended hemocytes were homogenized manually in
microtubes with a stainless steel micropestle. The homogenates
were centrifuged at 9000g for 10 min at 4 C, and the supernatants
were transferred into new 1.5-ml reaction tubes and stored at –
80 C until further analysis of enzyme activity and protein content
[11].
The proteasomal activities were determined by the hydrolysis
of ﬂuorogenic peptides [12]. Hydrolysis of Boc-Leu-Arg-Arg-MCA
(PeptaNova, product no. 3140) represents trypsin-like activity,
Suc-Leu-Leu-Val-Tyr-AMC (Enzo Life Sciences, product no. P-802)
represents chymotrypsin-like activity, and Z-Leu-Leu-Glu-AMC
(Enzo Life Sciences, product no. 9345) represents peptidyl-glutam-
yl peptide hydrolase (PGPH)-like activity. Epoxomicin, at concen-
trations between 2.5 and 100 lM, was used as a highly speciﬁc
inhibitor of the proteasome in all three assays [13].
The total volume of the enzymatic reaction mixture was 25 ll.
The enzyme assay consisted 17.5–20 ll of assay buffer, 2.5–5 ll
of sample, 1.25 ll of substrate, and 1.25 ll of inhibitor. All sub-
strates were prepared just prior to the measurement as 10- or
20-fold stock solutions dissolved in DMSO. The reactions were
started by the addition of the substrate into reaction tubes already
containing assay buffer and the samples that were adjusted for a
few minutes to the subsequent incubation conditions. The tubes
were immediately transferred to an Eppendorf thermomixer and
incubated at 30 C under permanent agitation (350 rpm). To deter-
mine the linearity of the enzymatic reaction, 2-ll aliquots of the
reaction mixture were removed from the tubes every 6–7 min for
up to 1 h and applied to the optical cell of the NanoDrop instru-
ment for ﬂuorescence measurement.
Endpoint measurements were done exactly after predetermined
periods of, for example, 1 h. For each enzyme assay, substrate
blanks were run in parallel to control the rate of autolysis of the
substrate during incubation. These blank assays contained only
buffer and the substrate, and no enzyme was added. Excitation
and emission wavelengths were 365 and 437 nm, respectively.
The reproducibility of the measurements of AMC ﬂuorescence
with the NanoDrop device was excellent. The standard curve was
linear (r2 = 0.999) for AMC concentrations up to 20 lM, which cor-
responded to approximately 52,000 relative ﬂuorescence units
(RFU) (Fig. 1). The deviation of the measured data from the calcu-
lated standard curve amounted to 5% on average. It was also much
lower in the higher concentration range than at the very low con-
centrations between 0.5 and 1 lM (Fig. 1).
The reproducibility of the standard measurements was in the
same range as, or even better than, that obtained by conventional
ﬂuorometry in 1-ml microcuvettes. The latter measurements
showed progressively decreasing ﬂuorescence at higher AMC con-
centrations, probably due to quenching effects. Nevertheless, the
correlation between the average values obtained by both methods
gave a coefﬁcient r2 of 0.998. For the quantiﬁcation of ﬂuorescence
data, we used the NanoDrop software, which is capable of applying
various curve ﬁts such as linear, cubic, and spline ﬁts.
The measurements of proteasomal activities showed a linear in-
crease of ﬂuorescence over time for each of the three substrates
(Fig. 2). Assays of PGPH-like activities that were inhibited with
epoxomicin showed a signiﬁcantly reduced, but also linear, in-
crease of ﬂuorescence due to remaining activity. No trypsin-like
and almost no chymotrypsin-like activities remained after inhibi-
tion with epoxomicin. The reproducibility of the measurements
was very good, with an overall average variation of less than 5%.
These results conﬁrm the applicability of NanoDrop ﬂuorome-
try for enzyme assays in very small samples and, thus, make this
method useful for studying precious proteasome inhibitors or
effectors [14–16]. A small amount of extract (50–100 ll) is more
than sufﬁcient to run all three proteasomal enzyme assays, includ-
ing controls and effectors, and to quantify protein as well. More-
over, the method enables ﬂuorogenic enzyme assays to be
conducted on small individual animals, which might be important
in environmental, ecophysiological, or ecotoxicological studies [8].
Despite the demonstrated advantages, this method also has
some disadvantages. The NanoDrop method can measure only
one sample at a time, and samples must be carefully applied so
that the volume is consistent and bubbles are avoided. Neverthe-
less, a skilled laboratory worker will be able to ﬁnish one measure-
ment within 30 s. Accordingly, this method is not applicable to
large-scale screening, but it is very well-suited for the explorative
screening of samples on a laboratory scale.
In conclusion, NanoDrop ﬂuorometry is a reliable and reproduc-
ible method for the measurement of proteasomal activities within
very small amounts of samples such as hemocytes. The signiﬁcant
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r2 = 0.999
Fig.1. Example of a standard curve for increasing AMC concentrations (0–20 lM, n = 44). The corresponding ﬂuorescence, as detected by the NanoDrop ND-3300 device, is
presented as relative ﬂuorescence units. The residues of each measurement (gray circles) are included on the graph. The dotted gray lines indicate a range of ±5% divergence.
The measurements scattered by less than ±5% in the range between 2.5 and 20 lM.
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advantage of using NanoDrop ﬂuorometry in enzymology is the
reduction of sample amount, substrates, and other reagents such
as cofactors and inhibitors. The method can be easily adopted for
other samples and substrates. The reduced sample volume allows
measurements on small organisms such as invertebrate larvae or
parts thereof, tissue samples obtained by biopsy, and small
amounts of cells from primary cultures or cell lines. The small scale
reduces the amount of reagents required for a single measurement
and simultaneously allows analyzing a larger number of individual
samples, thereby strengthening the statistical validity of any study.
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Fig.2. Increase of ﬂuorescence over time due to the hydrolysis of speciﬁc proteasomal substrates. Parallel assays were inhibited with epoxomicin. Averaged activities of the
three proteasomal enzymes are presented in the inset as bar charts. The black symbols and bars represent the uninhibited activities, and the white symbols and bars
represent the inhibited activities (means ± standard errors, n = 3).
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